These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 36414349)

  • 1. Kikuchi-Fujimoto disease following SARS-CoV-2 vaccination.
    Ikeda K; Kakehi E; Adachi S; Kotani K
    BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36414349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination.
    Kashiwada T; Saito Y; Terasaki Y; Shirakura Y; Shinbu K; Tanaka T; Tanaka Y; Seike M; Gemma A
    Hum Vaccin Immunother; 2022 Nov; 18(5):2071080. PubMed ID: 35583472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kikuchi-Fujimoto-like lymphadenopathy following COVID-19 vaccine: diagnosis and management.
    Betancur V; Net J; Chapman J; Yepes M
    BMJ Case Rep; 2022 Dec; 15(12):. PubMed ID: 36585044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fever with lymphadenopathy - Kikuchi Fujimoto disease, a great masquerader: a case report.
    Dalugama C; Gawarammana IB
    J Med Case Rep; 2017 Dec; 11(1):349. PubMed ID: 29246252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kikuchi Disease After SARS-CoV-2 Vaccination: A Case Report With Immunohistochemical Analyses.
    Hamamoto Y; Kawamura M; Mori H; Uchida H; Hiramatsu K; Katori C; Asai H; Kawasaki H; Minamino T; Hashimoto M; Nakatsuka SI; Yoshida K
    Int J Surg Pathol; 2024 Sep; 32(6):1123-1128. PubMed ID: 37981745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kikuchi-Fujimoto disease presenting in a patient with SARS-CoV-2: a case report.
    Racette SD; Alexiev BA; Angarone MP; Bhasin A; Lima K; Jennings LJ; Balasubramanian S; Matsuoka AJ
    BMC Infect Dis; 2021 Aug; 21(1):740. PubMed ID: 34344305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kikuchi-Fujimoto Disease and Prognostic Implications.
    Salamat S; Chan J; Jolly K; Powell G; Harrison K; Ahanger S; Hari C
    Head Neck Pathol; 2020 Mar; 14(1):272-275. PubMed ID: 30888636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance approach.
    Rodríguez-Ferreras A; Maray I; Coya-Fernández C; Octavio-Bocigas MM; Fernández-Del Río MF; Casares-López S; Ruiz-Salazar J
    Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):278-282. PubMed ID: 36458479
    [No Abstract]   [Full Text] [Related]  

  • 9. A familial case of Kikuchi-Fujimoto disease in dizygotic twins.
    Quadir A; Peacock K; Hsu P; Singh-Grewal D; Alexander S
    Pediatr Rheumatol Online J; 2020 Aug; 18(1):62. PubMed ID: 32778173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histiocytic necrotising lymphadenitis (Kikuchi-Fujimoto disease) of axillary lymph nodes.
    Nagaraju S; Vaishnav S; Burke LH; Norman EM
    BMJ Case Rep; 2015 Jan; 2015():. PubMed ID: 25564582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kikuchi-Fujimoto disease following vaccination against human papilloma virus infection and Japanese encephalitis.
    Watanabe T; Hashidate H; Hirayama Y; Iinuma Y
    Eur J Pediatr; 2012 Sep; 171(9):1409-11. PubMed ID: 22476507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kikuchi-Fujimoto disease mimicking T-cell lymphoma after COVID-19 vaccination.
    Sumransub N; Bachanova V; Linden MA
    Am J Clin Pathol; 2024 Aug; 162(2):210. PubMed ID: 38460113
    [No Abstract]   [Full Text] [Related]  

  • 13. [Kikuchi-Fujimoto lymphadenitis in a 29-year-old female patient].
    Magutová J
    Internist (Berl); 2016 Jan; 57(1):90-3. PubMed ID: 26684186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kikuchi disease complicated with aseptic meningitis following COVID-19 Vaccination: a case report.
    Kularathna MDSV; Medagama A; Bandara R; Yasarathna D; Dilani MKI; Anuththara T
    J Med Case Rep; 2024 Jun; 18(1):270. PubMed ID: 38840233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kikuchi-Fujimoto Disease Following COVID-19 Vaccination: Experience at a Population-Based Referral Center.
    Craig JW; Farinha P; Jiang A; Lytle A; Skinnider B; Slack GW
    Am J Clin Pathol; 2023 Aug; 160(2):114-118. PubMed ID: 37526500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kikuchi-Fujimoto disease: a rare cause of cervical lymphadenopathy and fever.
    Wong YK; Khan M
    BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30097545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case of Recurrent Cervical Lymphadenopathy Due to Kikuchi-Fujimoto Disease.
    Alsolami A; Altirkistani R; Tayeb S; Albeshri T; Estaitieh O; Rabie N; Fadag R; Samannodi M
    Am J Case Rep; 2021 Feb; 22():e928760. PubMed ID: 33583938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kikuchi-Fujimoto Disease: A Case of SARS-CoV-2 Infection Triggering the Rare Disease.
    Lencastre Monteiro R; Cabaço S; Soares L; Inácio H; Nazário Leão R
    Cureus; 2023 Mar; 15(3):e35858. PubMed ID: 37033518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful management of Kikuchi-Fujimoto disease caused by SARS-CoV-2].
    Iszlai Z; Török L; Tóth E; Karosi T
    Orv Hetil; 2022 Jul; 163(27):1061-1065. PubMed ID: 35895470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kikuchi-Fujimoto disease following SARS-CoV-2 infection: A rare disease with increased incidence during the COVID-19 pandemic?
    Leung CCD; Chan HCC; Chan MC; Chan YH; Ho MY; Chen CH; Ngai CM; Yeung YC
    Respirol Case Rep; 2024 Jun; 12(6):e01414. PubMed ID: 38903947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.